These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37584182)

  • 1. Drastic alterations in the loop structure around colchicine upon complex formation with an engineered lipocalin indicate a conformational selection mechanism.
    Jerschke E; Eichinger A; Skerra A
    Acta Crystallogr F Struct Biol Commun; 2023 Sep; 79(Pt 9):231-239. PubMed ID: 37584182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An engineered lipocalin that tightly complexes the plant poison colchicine for use as antidote and in bioanalytical applications.
    Barkovskiy M; Ilyukhina E; Dauner M; Eichinger A; Skerra A
    Biol Chem; 2019 Feb; 400(3):351-366. PubMed ID: 30517073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies.
    Schönfeld D; Matschiner G; Chatwell L; Trentmann S; Gille H; Hülsmeyer M; Brown N; Kaye PM; Schlehuber S; Hohlbaum AM; Skerra A
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8198-203. PubMed ID: 19416843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structure and dynamics of the engineered fluorescein-binding lipocalin FluA reveal rigidification of beta-barrel and variable loops upon enthalpy-driven ligand binding.
    Mills JL; Liu G; Skerra A; Szyperski T
    Biochemistry; 2009 Aug; 48(31):7411-9. PubMed ID: 19603796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-guided engineering of Anticalins with improved binding behavior and biochemical characteristics for application in radio-immuno imaging and/or therapy.
    Eggenstein E; Eichinger A; Kim HJ; Skerra A
    J Struct Biol; 2014 Feb; 185(2):203-14. PubMed ID: 23542582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called Anticalins.
    Achatz S; Jarasch A; Skerra A
    J Struct Biol X; 2022; 6():100054. PubMed ID: 34988429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial design of an Anticalin directed against the extra-domain b for the specific targeting of oncofetal fibronectin.
    Gebauer M; Schiefner A; Matschiner G; Skerra A
    J Mol Biol; 2013 Feb; 425(4):780-802. PubMed ID: 23238252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative binding proteins: anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities.
    Skerra A
    FEBS J; 2008 Jun; 275(11):2677-83. PubMed ID: 18435758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticalins small engineered binding proteins based on the lipocalin scaffold.
    Gebauer M; Skerra A
    Methods Enzymol; 2012; 503():157-88. PubMed ID: 22230569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins.
    Richter A; Eggenstein E; Skerra A
    FEBS Lett; 2014 Jan; 588(2):213-8. PubMed ID: 24239535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tetrahedral Boronic Acid Diester Formed by an Unnatural Amino Acid in the Ligand Pocket of an Engineered Lipocalin.
    Sommer CA; Eichinger A; Skerra A
    Chembiochem; 2020 Feb; 21(4):469-472. PubMed ID: 31390134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity recognition of lanthanide(III) chelate complexes by a reprogrammed human lipocalin 2.
    Kim HJ; Eichinger A; Skerra A
    J Am Chem Soc; 2009 Mar; 131(10):3565-76. PubMed ID: 19227970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The menagerie of human lipocalins: a natural protein scaffold for molecular recognition of physiological compounds.
    Schiefner A; Skerra A
    Acc Chem Res; 2015 Apr; 48(4):976-85. PubMed ID: 25756749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticalin® proteins: from bench to bedside.
    Deuschle FC; Ilyukhina E; Skerra A
    Expert Opin Biol Ther; 2021 Apr; 21(4):509-518. PubMed ID: 33074019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region.
    Korndörfer IP; Beste G; Skerra A
    Proteins; 2003 Oct; 53(1):121-9. PubMed ID: 12945055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural mechanism of specific ligand recognition by a lipocalin tailored for the complexation of digoxigenin.
    Korndörfer IP; Schlehuber S; Skerra A
    J Mol Biol; 2003 Jul; 330(2):385-96. PubMed ID: 12823976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo neutralization of colchicine toxicity by a PASylated anticalin in a rat model.
    Jerschke E; Barkovsky M; Jung N; Neuberger H; Stenzel J; Eyer F; Skerra A; Geith S
    Toxicology; 2023 Jun; 492():153526. PubMed ID: 37116682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rational engineering of a fluorescein-binding anticalin for improved ligand affinity.
    Vopel S; Mühlbach H; Skerra A
    Biol Chem; 2005 Nov; 386(11):1097-104. PubMed ID: 16307475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant -- a so-called 'anticalin' -- using a molecular random approach.
    Schlehuber S; Skerra A
    Biophys Chem; 2002 May; 96(2-3):213-28. PubMed ID: 12034442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Design of an Anticalin-Type Sugar-Binding Protein Using a Genetically Encoded Boronate Side Chain.
    Edwardraja S; Eichinger A; Theobald I; Sommer CA; Reichert AJ; Skerra A
    ACS Synth Biol; 2017 Dec; 6(12):2241-2247. PubMed ID: 28937743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.